217 related articles for article (PubMed ID: 16856128)
1. Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer.
Duric VM; Butow PN; Sharpe L; Boyle F; Beith J; Wilcken NR; Heritier S; Coates AS; John Simes R; Stockler MR
Psychooncology; 2007 Jan; 16(1):48-59. PubMed ID: 16856128
[TBL] [Abstract][Full Text] [Related]
2. Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer.
Duric VM; Butow PN; Sharpe L; Heritier S; Boyle F; Beith J; Wilcken NR; Coates AS; Simes RJ; Stockler MR
Patient Educ Couns; 2008 Aug; 72(2):239-45. PubMed ID: 18434070
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for early colon cancer: what survival benefits make it worthwhile?
Blinman P; Duric V; Nowak AK; Beale P; Clarke S; Briscoe K; Boyce A; Goldstein D; Hudson M; Stockler M
Eur J Cancer; 2010 Jul; 46(10):1800-7. PubMed ID: 20137908
[TBL] [Abstract][Full Text] [Related]
4. Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?
Duric VM; Stockler MR; Heritier S; Boyle F; Beith J; Sullivan A; Wilcken N; Coates AS; Simes RJ
Ann Oncol; 2005 Nov; 16(11):1786-94. PubMed ID: 16126738
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting patients' perceptions of choice regarding adjuvant chemotherapy for breast cancer.
Jansen SJ; Otten W; Stiggelbout AM
Breast Cancer Res Treat; 2006 Sep; 99(1):35-45. PubMed ID: 16541318
[TBL] [Abstract][Full Text] [Related]
6. Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile.
Duric V; Stockler M
Lancet Oncol; 2001 Nov; 2(11):691-7. PubMed ID: 11902540
[TBL] [Abstract][Full Text] [Related]
7. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy.
Browall MM; Ahlberg KM; Persson LO; Karlsson PO; Danielson EB
Acta Oncol; 2008; 47(2):207-15. PubMed ID: 18210297
[TBL] [Abstract][Full Text] [Related]
8. Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer.
Schreier AM; Williams SA
Oncol Nurs Forum; 2004; 31(1):127-30. PubMed ID: 14722597
[TBL] [Abstract][Full Text] [Related]
9. Same gain, less pain: potential patient preferences for adjuvant treatment in premenopausal women with early breast cancer.
Fallowfield L; McGurk R; Dixon M
Eur J Cancer; 2004 Nov; 40(16):2403-10. PubMed ID: 15519512
[TBL] [Abstract][Full Text] [Related]
10. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
Adjuvant Breast Cancer Trials Collaborative Group
J Natl Cancer Inst; 2007 Apr; 99(7):506-15. PubMed ID: 17405995
[TBL] [Abstract][Full Text] [Related]
11. Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
Jansen SJ; Kievit J; Nooij MA; de Haes JC; Overpelt IM; van Slooten H; Maartense E; Stiggelbout AM
Br J Cancer; 2001 Jun; 84(12):1577-85. PubMed ID: 11401308
[TBL] [Abstract][Full Text] [Related]
12. A qualitative study of factors affecting chemotherapy use in older women with breast cancer: barriers, promoters, and implications for intervention.
Kreling B; Figueiredo MI; Sheppard VL; Mandelblatt JS
Psychooncology; 2006 Dec; 15(12):1065-76. PubMed ID: 16598833
[TBL] [Abstract][Full Text] [Related]
13. Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?
Blinman P; Hughes B; Crombie C; Christmas T; Hudson M; Veillard AS; Muljadi N; Millward M; Wright G; Flynn P; Windsor M; Stockler M; McLachlan SA;
Eur J Cancer; 2015 Aug; 51(12):1529-37. PubMed ID: 26059196
[TBL] [Abstract][Full Text] [Related]
14. Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment.
Niikura N; Kimura M; Iwamoto T; Hayashi N; Shintoku J; Saito Y; Suzuki Y; Tokuda Y
Breast Cancer; 2013 Jan; 20(1):67-74. PubMed ID: 22109640
[TBL] [Abstract][Full Text] [Related]
15. Side effects of adjuvant chemotherapy: perceptions of node-negative breast cancer patients.
Beisecker A; Cook MR; Ashworth J; Hayes J; Brecheisen M; Helmig L; Hyland S; Selenke D
Psychooncology; 1997 Jun; 6(2):85-93. PubMed ID: 9205966
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
Lueboonthavatchai P
J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
[TBL] [Abstract][Full Text] [Related]
17. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?
Simes RJ; Coates AS
J Natl Cancer Inst Monogr; 2001; (30):146-52. PubMed ID: 11773309
[TBL] [Abstract][Full Text] [Related]
18. Justifying adjuvant chemotherapy in breast cancer: a survey of women and healthcare professionals.
Sweeney KJ; Ryan E; Canney M; O'Daly BJ; Kerin MJ
Eur J Surg Oncol; 2007 Sep; 33(7):838-42. PubMed ID: 17267166
[TBL] [Abstract][Full Text] [Related]
19. Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.
Julian-Reynier C; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; Maraninchi D;
J Clin Oncol; 2007 Jul; 25(21):3038-44. PubMed ID: 17536083
[TBL] [Abstract][Full Text] [Related]
20. Patients' reactions to completion of adjuvant breast cancer therapy.
Ward SE; Viergutz G; Tormey D; deMuth J; Paulen A
Nurs Res; 1992; 41(6):362-6. PubMed ID: 1437586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
